US Patent Issued to Juno Therapeutics on Aug. 11 for "Process for producing donor-batched cells expressing a recombinant receptor" (Washington Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,733, issued on Aug. 11, was assigned to Juno Therapeutics Inc. (Seattle).

"Process for producing donor-batched cells expressing a recombinant receptor" was invented by Nathan Yee (Seattle), Ryan Larson (Seattle), Calvin Chan (Seattle), Sara Cooper (Seattle), Jeffrey Teoh (Seattle), Daniel Cossette (Seattle) and Kohana Leuba (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of producing engineered T cell compositions enriched for CD57 negative and/or CD27 positive T cells, such as from a plurality of donors. In some embodiments, the T cells are engineered with a recombinant receptor, such as a chimeric antigen recept...